Why TRT Raised Your Blood Pressure (and How to Fix It)

Your blood pressure went up after starting testosterone. Your doctor may have told you that's just what happens on TRT, or maybe nobody told you anything at all. But the reason it happens is specific, and so is the fix, and understanding the mechanism is the difference between managing this well and just hoping it gets better.

Start with the full picture. Testosterone is not one thing doing one thing. When you introduce exogenous testosterone, your body responds to it across multiple systems at the same time, and three of those responses have a direct effect on blood pressure. They are not all the same size, they are not all from the same mechanism, and fixing one without addressing the others will leave you stuck. So here is the map before the detail.

Your blood gets thicker from more red blood cells, excess estrogen causes your body to hold water, and your cardiovascular system is trying to push a larger blood volume through a system that has not adapted to handle it. Three levers. Three different fixes. All three matter.

Start with hematocrit, because this is the biggest one. Testosterone triggers something called erythropoiesis, which is your body producing new red blood cells, and it does this by stimulating the kidneys to release erythropoietin, a hormone that tells your bone marrow to ramp up production. The relevant finding here is that this effect is dose dependent, meaning the more testosterone you take, the more red blood cells you make, and hemoglobin and hematocrit rise in a linear fashion as the dose goes up.

The blood pressure problem this creates is a physics problem. Blood is not water. It has viscosity, which is resistance to flow, and when you pack more red blood cells into the same volume of plasma, that blood becomes thicker and harder to push through your vessels, so your heart has to work harder and your pressure goes up. A randomized controlled trial captured exactly this: men whose hematocrit rose more than 6 percent on testosterone saw their systolic blood pressure increase by 13.2 millimeters of mercury compared to placebo. That is not a small number. That is the difference between a normal reading and a reading that warrants a clinical conversation.

The threshold that signals you need to act is a hematocrit above 54 percent. Below that, the risk profile changes, and the standard recommendation is dose reduction or temporary discontinuation if you cross it. Getting your hematocrit checked every six months is not optional monitoring, it is how you keep this lever from becoming a problem.

The second mechanism is estradiol, and this one is worth understanding carefully because the standard clinical response to it often makes things worse. Testosterone does not stay testosterone. Your body converts a portion of it into estradiol through a process called aromatization, which happens primarily in fat tissue. When estradiol rises significantly above the normal range, it increases something called extracellular water retention, which is water that accumulates outside your cells, and research has confirmed that testosterone independently increases extracellular water through effects on the renal tubules in your kidneys. More water in your vascular space means more volume pressing against your vessel walls, which means higher pressure.

The intervention many clinics reach for is an aromatase inhibitor, something that blocks the conversion of testosterone to estradiol, and in theory this addresses the water retention. But here is where this commonly goes wrong. Estradiol is not just a side effect of TRT. It plays an active protective role in the cardiovascular system, and when you block aromatase aggressively and push estradiol too low, blood pressure can increase from that direction as well. Animal research has shown that blocking aromatase directly raises mean arterial pressure, and the mechanism makes sense because estradiol supports nitric oxide production in vessel walls, which keeps those vessels relaxed and open.

So you are not trying to eliminate estradiol. You are trying to keep it in a range where it is doing its protective job without causing water retention, and that range in clinical practice is generally 20 to 40 picograms per milliliter on a sensitive estradiol test. The better way to stay in that range is not by adding an aromatase inhibitor but by adjusting injection frequency, because more frequent smaller injections produce lower peak testosterone levels and therefore less conversion to estradiol at any single point in time.

The third mechanism does not show up in any lab value, which is why it gets ignored. TRT increases your blood volume. Your cardiovascular system has to adapt to move that larger volume efficiently, and the way it adapts is through something called cardiac remodeling, where your heart becomes a more capable pump and your vessels become more responsive. But that adaptation requires a stimulus, and the stimulus is aerobic exercise.

Without cardio, your heart is being asked to manage a job it has not trained for. The increased volume becomes a sustained load without the physiological changes that would let your body handle it gracefully, and blood pressure stays elevated as a result. This is not a theoretical concern. It is a direct consequence of increasing blood volume in a system that has not developed the capacity to match it.

Now here is what changes the whole picture. When all three of these are managed, the long-term trajectory of blood pressure on TRT is not upward, it is downward. A study following 737 men on testosterone found that those not on blood pressure medication saw their systolic drop by approximately 12.5 points over the study period. In another cohort of 202 men on antihypertensives, 33 of them were able to discontinue their blood pressure medication entirely after sustained TRT.

The reason that is possible comes back to the system. Testosterone, when it is not raising hematocrit excessively, not pushing estradiol out of range, and not being administered to a cardiovascular system that has no aerobic capacity, actually improves vascular function and metabolic health in ways that reduce blood pressure over time.

TRT raising your blood pressure is a signal that something in the protocol is unmanaged, not a fundamental property of the therapy itself.

---

References

1. Olesen TB, Glintborg D, Johnk F, et al. 2024. Blood pressure responses to testosterone therapy are amplified by hematocrit levels in opioid-induced androgen deficiency. Journal of Hypertension, 423, 531-540. Finding: Office SBP increased 6.2 mmHg in testosterone group vs 7.0 mmHg decrease in placebo net 13.2 mmHg. Men with hematocrit rise >6% saw clinically relevant BP increases. Source
2. Coviello AD, Kaplan B, Lakshman KM, et al. 2008. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. Journal of Clinical Endocrinology and Metabolism, 933, 914-919. Finding: Hemoglobin and hematocrit increased in a linear, dose-dependent fashion. Source
3. Almutlaq RN, Newell-Fugate AE, Evans LC, et al. 2022. Aromatase inhibition increases blood pressure and markers of renal injury in female rats. American Journal of Physiology Renal Physiology, 3232, F170-F181. Finding: Blocking aromatase increased mean arterial pressure. Source
4. Hackett G, Mann A, Haider A, et al. 2024. Testosterone replacement therapy: effects on blood pressure in hypogonadal men. World Journal of Mens Health, 422, 431-443. Finding: Long-term TRT associated with significant SBP and DBP reductions. 33 of 202 men on antihypertensives discontinued them. Source
5. Agrawal P, Singh SM, Kohn T. 2023. Management of erythrocytosis in men receiving testosterone therapy. European Urology Focus, 91, 139-142. Finding: Hematocrit >54% requires dose decrease or discontinuation. Source
6. Johannsson G, Gibney J, Wolthers T, et al. 2005. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. Journal of Clinical Endocrinology and Metabolism, 907, 3891-3896. Finding: Testosterone independently increased extracellular water through renal tubule effects. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness